Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | FULC | CRMD | ||
| Company | Urovant Sciences Ltd | Fulcrum Therapeutics Inc | Cormedix Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 7.94 | 6.73 | ||
| High | 16.24 | 8.07 | 6.82 | ||
| Low | 16.21 | 7.49 | 6.51 | ||
| Latest | 16.24 | 7.79 | 6.69 | ||
| Change | +0.01 | -0.22 | -0.03 | ||
| % Change | +0.06% | -2.75% | -0.45% | ||
| Volume | 1,739,000 | 1,058,900 | 1,395,800 | ||
| 20-Day Average Volume | 143,510 | 1,257,655 | 1,688,980 | ||
| Previous Close | 16.23 | 8.01 | 6.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 9.32 | 7.02 | ||
| 20-Day Raw Stochastic | 87.10% | 6.61% | 34.14% | ||
| 20-Day Relative Strength | 65.56 | 37.24 | 38.91 | ||
| Weighted Alpha | +6.45 | +8.43 | -16.11 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 96% Buy | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -6.71% since 03/04/26 | -6.04% since 03/04/26 | ||
| Low | 16.20 on 03/24/21 | 7.49 on 03/11/26 | 6.13 on 03/06/26 | ||
| High | 16.25 on 03/25/21 | 8.45 on 03/06/26 | 6.86 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -28.33% since 02/11/26 | -9.96% since 02/11/26 | ||
| Low | 16.10 on 03/02/21 | 7.49 on 03/11/26 | 6.13 on 03/06/26 | ||
| High | 16.26 on 03/19/21 | 12.03 on 02/19/26 | 7.74 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -39.14% since 12/11/25 | -43.02% since 12/11/25 | ||
| Low | 16.03 on 12/30/20 | 7.49 on 03/11/26 | 6.13 on 03/06/26 | ||
| High | 16.26 on 03/19/21 | 13.26 on 12/15/25 | 13.02 on 12/30/25 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +11.44% since 09/11/25 | -48.89% since 09/11/25 | ||
| Low | 7.15 on 11/02/20 | 6.69 on 09/15/25 | 6.13 on 03/06/26 | ||
| High | 16.26 on 03/19/21 | 15.74 on 12/08/25 | 13.30 on 09/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 533,466 | 531,216 | ||
| Shares Outstanding, K | 32,743 | 66,600 | 79,050 | ||
| Annual Sales | 0 | 0 | 311,710,000 | ||
| Annual Net Income | -146,750,000 | -74,880,000 | 163,060,000 | ||
| Last Quarter Sales | 0 | 0 | 128,620,000 | ||
| Last Quarter Net Income | -46,800,000 | -20,330,000 | 14,020,000 | ||
| 60-Month Beta | 2.35 | 3.23 | 1.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.31 on 10/29/25 | 0.16 on 03/05/26 | ||
| Latest Earnings Date | 06/17/21 | 05/07/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 3.73 | ||